Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-17-002974)

Filing Details

Accession Number:: 0001179110-17-002974
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-22 18:18:08
Reporting Period:: 2017-02-17

Filing Date:: 2017-02-22
Accepted Time:: 2017-02-22 18:18:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1800	Abbott Laboratories	ABT	Pharmaceutical Preparations (2834)	360698440

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1695686	J Joseph Manning	100 Abbott Park Road Abbott Park IL 60064	Senior Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares Without Par Value	Disposition	2017-02-21	287	$44.69	20,292	No	4	F	Direct
Common Shares Without Par Value	Disposition	2017-02-21	146	$44.98	20,146	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Option (right to buy)	Acquisiton	2017-02-17	92,032	$0.00	92,032	$44.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
92,032	2018-02-17	2027-02-16	No	4	A	Direct

Footnotes

Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,678 on 2/17/2018, 30,677 on 2/17/2019, and 30,677 on 2/17/2020.